Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $7.7 million.

  • Select Medical Holdings' Net Cash Flow fell 9040.57% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$131.4 million, marking a year-over-year decrease of 21524.71%. This contributed to the annual value of -$24.3 million for FY2024, which is 7490.65% down from last year.
  • Latest data reveals that Select Medical Holdings reported Net Cash Flow of $7.7 million as of Q3 2025, which was down 9040.57% from -$864000.0 recorded in Q2 2025.
  • Select Medical Holdings' 5-year Net Cash Flow high stood at $173.2 million for Q1 2021, and its period low was -$673.7 million during Q4 2021.
  • Over the past 5 years, Select Medical Holdings' median Net Cash Flow value was $6.6 million (recorded in 2023), while the average stood at -$27.2 million.
  • Within the past 5 years, the most significant YoY rise in Select Medical Holdings' Net Cash Flow was 43846.67% (2024), while the steepest drop was 210691.44% (2024).
  • Select Medical Holdings' Net Cash Flow (Quarter) stood at -$673.7 million in 2021, then soared by 98.47% to -$10.3 million in 2022, then skyrocketed by 163.64% to $6.6 million in 2023, then plummeted by 2106.91% to -$131.8 million in 2024, then skyrocketed by 105.85% to $7.7 million in 2025.
  • Its Net Cash Flow was $7.7 million in Q3 2025, compared to -$864000.0 in Q2 2025 and -$6.5 million in Q1 2025.